Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Systematic Reviews
Published in: Systematic Reviews 1/2021

Open Access 01-12-2021 | Cervical Cancer | Research

Precancerous cervical lesion in Ethiopia: systematic review and meta-analysis

Authors: Ayele Semachew Kasa, Tadesse Dagget, Yeshiwork Beyene, Getnet Dessie, Aklilu Endalamaw, Yinager Workineh, Emiru Ayalew, Balew Zeleke, Sitotaw Kerie, Getasew Mulat, Worku Animaw

Published in: Systematic Reviews | Issue 1/2021

Login to get access

Abstract

Background

Though cervical cancer is largely preventable, it is still the second most common female cancer globally and the leading cause of cancer deaths among females in African. Though many efforts have been done to study the burden of the disease in Ethiopia, primary studies examining the prevalence of precancerous cervical lesions are fragmented. Hence, this systematic review and meta-analysis is aimed at estimating the pooled prevalence of precancerous cervical lesion and its trends in Ethiopia.

Methods

This systematic review and meta-analysis was conducted using the following electronic databases. PubMed, Web of Science, SCOPUS, Science Direct, Google Scholar, African Index Medicus (AIM), African Journals Online databases, and Addis Ababa and Bahir Dar Universities research repositories were searched following the Preferred Items for Systematic Review and Meta-analysis (PRISMA) Guideline. STATA 15 statistical software was used to analyze the data. The quality of the included studies was assessed using the Joanna Briggs Institute (JBI) quality appraisal tool for meta-analysis. Heterogeneity between studies was assessed using the Cochrane Q test and I2 test statistics based on the random effects model. A random effects model was computed to estimate the pooled prevalence of precancerous cervical lesion in Ethiopia. Finally, the trend of precancerous cervical lesion in the country was presented.

Result

Seventeen studies with a total of 26,112 participants were included in the analysis. The pooled prevalence of precancerous cervical lesion was 15.16 (95% CI 10.16–19.70). The subgroup analysis by region showed the highest prevalence of precancerous cervical lesion at the Southern Nations and Nationalities Peoples Region (19.65%; 95% CI 15.51–23.80). The trend of precancerous cervical lesion prevalence showed an increased pattern over time.

Conclusion

Approximately one among six of the study participants had precancerous cervical lesion. The trend also showed that there is still an increasing precancerous cervical lesion in Ethiopia. Best practices in achieving high vaccination coverage shall be informed by practices in other successful countries.
Literature
1.
American Cancer Society. Cancer facts & figures. 2011. p. 4.
2.
Kasa AS, Tesfaye TD, Temesgen WA. Knowledge, attitude and practice towards cervical cancer among women in Finote Selam city administration, West Gojjam Zone, Amhara Region, North West Ethiopia, 2017. Afr Health Sci. 2018;18(3):623–36.PubMedPubMedCentralCrossRef
3.
Getahun F, Mazengia F, Abuhay MBZ. Comprehensive knowledge about cervical cancer is low among women in Northwest Ethiopia. BMC Cancer. 2013;13(2):1–7.
4.
Eke NO, et al. Knowledge of cervical cancer and its screening amongst female workers in Nnewi, Nigeria. Afri Med J. 2010;1(1):1–6.
5.
Adamu AN, et al. The effect of health education on the knowledge, attitude, and uptake of free Pap smear among female teachers in Birnin Kebbi, North-Western Nigeria. Niger J Clin Pr. 2012;15(3):15–23.
6.
Desta K, et al. The effect of HIV coinfection, HAART and TB treatment on cytokine/chemokine responses to Mycobacterium tuberculosis (Mtb) antigens in active TB patients and latently Mtb infected individuals. Tuberculosis. 2016;96:131–40.
7.
Mccarey C. et. Awareness of HPV and cervical cancer prevention among Cameroonian healthcare workers. BMC Womens Heal. 2011;11(45):1–7.
8.
Ferlay J, et al. Estimates of worldwide burden of cancer in 2008. Int J Cancer. 2010;127:2893–917.PubMedCrossRef
9.
Anantharaman VV. A cross-sectional study on knowledge, attitude, and practice on cervical cancer and screening among female health care providers of Chennai corporation. J Acad Med Sci. 2013;2(4):124–8.
10.
Denny L, et al. Human papillomavirus infection and cervical disease in human immunodeficiency virus-1-infected women. ObstetGynecol. 2008;111:1380–7.
11.
Wondimu YT. Cervical cancer: assessment of diagnosis and treatment facilities in public health institutions in Addis Ababa. Ethiopia. Ethiop Med J. 2015;53:65–74.PubMed
12.
13.
Wittet S. Cervical cancer prevention and the millennium development goals. Bull World Heal Organ. 2008;86:488–90.CrossRef
14.
Bailie RS, et al. Trends in cervical cancer mortality in South Africa. Int J Epidemiol. 1996;25:488–93.PubMedCrossRef
15.
Al FM. et. Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet. 2011;378(7):1–10.
16.
17.
Louie KS, et al. Epidemiology and prevention of human papillomavirus and cervical cancer in sub-Saharan Africa: a comprehensive review. Trop Med Int Heal. 2009;14:1287–302.CrossRef
18.
WHO/ICO. Human papilomavirus and related cancers in Ethiopia: summary report. 2014.
19.
Waktola EA, Mihret WBL. HPV and burden of cervical cancer in east Africa. GynecolOncol. 2005;99:201–2.
20.
Jemal A. et. Cancer burden in Africa and opportunities for prevention. Cancer. 2009;118:4372–84.CrossRef
21.
Tesfa A. Combating cervical cancer in Ethiopia; 2015. p. 1–3.
22.
World Health Organization. Human papilloma virus and related cancers in Ethiopia: summary report; 2009. p. 1–5.
23.
Bruni L et al.. ICO Information Centre on HPV and Cancer (HPV Information Centre). Human papillomavirus and related diseases in Ethiopia. Summary Report 2014. 2014. Available from: www.​hpvcentre.​net
24.
Moher D, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(6):1000097.CrossRef
25.
The Joanna Briggs Institute. Checklist for analytical cross sectional studies; 2016. p. 3–4.
26.
Aklilu E, Setegn E, Tesfa D. A systematic review and meta-analysis of vertical transmission route of HIV in Ethiopia. BMC Infect Dis. 2018;18:283.CrossRef
27.
Derbie A, Mekonen D, Mezgebu Y, Biadglegne F. Cervical lesion detection using visual inspection with acetic acid and associated factors among Ethiopian women. Ethiop Med J. 2019;57(2):1–9.
28.
Belayneh T, Habtamu Mitiku FW. Precancerous cervical lesion and associated factors among HIV-infected women on ART in Amhara Regional State, Ethiopia: a hospital-based cross-sectional study. Int J Heal Sci Res. 2019;13(3):1–6.
29.
Bedassa BB. Acceptability of cervical cancer screening using See and Treat (SAT) approach and determinant factors among women of reproductive age in health centers in Addis Ababa, Ethiopia: Addis Ababa University; 2017.
30.
Gedefaw A, Astatkie A, Tessema GA. The prevalence of precancerous cervical cancer lesion among HIV-infected the prevalence of precancerous cervical cancer lesion among HIV-infected women in Southern Ethiopia: a cross-sectional study. PLoS One. 2013;8(12):1–9.CrossRef
31.
Getinet M, Gelaw B, Sisay A, Mahmoud EAA. Prevalence and predictors of Pap smear cervical epithelial cell abnormality among HIV-positive and negative women attending gynecological examination in cervical cancer screening center at Debre Markos referral hospital, East Gojjam, Northwest Ethiopia. BMC Clin Pathol. 2015;15(16):1–10. Available from:. https://​doi.​org/​10.​1186/​s12907-015-0016-2.CrossRef
32.
Hailemariam T, Yohannes B, Aschenaki H, Mamaye EOG, et al. Cancer science & therapy prevalence of cervical cancer and associated risk factors among women attending cervical cancer screening and diagnosis center at Yirgalem. J Cancer Sci Ther. 2017;9(11):730–5.CrossRef
33.
Kassa S, Dile M, Zenebe KBM. Precancerous lesions of cervix among women infected with HIV in Referral Hospitals of Amhara Region, Northwest Ethiopia: a cross sectional study. Afr Health Sci. 2019;19(1):1–10.CrossRef
34.
Kebede M, Belay SAH. Prevalence of precancerous cervical lesion and associated factors among women in North Ethiopia. J Public Heal Epidemiol Full. 2017;9(March):46–50.CrossRef
35.
Meseret ATM. Prevalence of via positive cervical lesions and determinant factors among women attending regular gynecology outpatient department (RGOPD) at Saint Paul’s Hospital Millennium Medical College (SPHMMC). Ethiop J Reprod Heal. 2018;10(2):22–30.
36.
Netsanet S, Salvador-Davila KK, Brooks M, Weldegebreal T, et al. The single-visit approach as a cervical cancer prevention strategy among women with HIV in Ethiopia: successes and lessons learned. Glob Heal Sci Pract. 2016;4(1):87–98.CrossRef
37.
38.
Ruland R, Prugger C, Schiffer R, Regidor M, Lelle RJ. Prevalence of human papilloma virus infection in women in rural Ethiopia. Springer. 2006;21:727–8.
39.
SamiSami-Ramzi L-B, Prugger C, GH KM, et al. Cervical human papillomavirus prevalence and genotype distribution among hybrid capture 2 positive women 15 to 64 years of age in the Gurage zone, rural Ethiopia. Infect Agent Cancer. 2014;9(33):1–9.
40.
Teame H, Addissie A, Ayele W, Hirpa S, Gebremariam A, et al. Factors associated with cervical precancerous lesions among women screened for cervical cancer in Addis Ababa, Ethiopia: a case control study. PLoS One. 2018;39:1–13.
41.
Teka T, Kote M, Kejela GGT. Magnitude and factors associated with precervical cancer among screened women in Southern Ethiopia. Adv Public Heal. 2019;10:1–9.
42.
Temesgen K, Workie A, Dilnesa TAM. Proportions of pre-cancerous cervical lesions and its associated factors among women clients in the age group of 30-49yrs in gynecology ward of Dessie Referral Hospital and FGAE. North-East. J Cancer Tumor Int. 2019;9(2):1–15.
43.
Zewdie M, Tesfamichael AFA. Prevalence and factors associated with VIA positive result among clients screened at Family Guidance Association of Ethiopia, south west area office, Jimma model clinic, Jimma, Ethiopia 2013: a cross-sectional study. BMC Res Notes. 2015;8(618):1–7.
44.
Huedo-Medina TB, et al. Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychol Methods. 2006;11(2):193.PubMedCrossRef
45.
Giggings, Thompson D and A, Measuring inconsistency in meta-analyses. Br Med J. 2003;327(7414):557.CrossRef
46.
Borenstein M, et al. A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synt Methods. 2010;1(2):97–111.CrossRef
47.
Rendina-Gobioff G. et al. Detecting publication bias in random effects metaanalysis: an empirical comparison of statistical methods. 2006.
48.
Kelley GAKK. Statistical models for meta-analysis: a brief tutorial. World J Methodol. 2012;2(4):2012.CrossRef
49.
Jackson D, et al. How does the DerSimonian and Laird procedure for random effects meta-analysis compare with its more efficient but harder to compute counterparts? J Stat Plann Inference. 2010;140(4):961–70.CrossRef
50.
Bayu H, Berhe Y, Mulat A, Alemu A. Cervical cancer screening service uptake and associated factors among age eligible women in Mekelle Zone, Northern Ethiopia, 2015: a community based study using health belief model. PLoS One. 2016;11(3):1–13.CrossRef
51.
Gebremariam T. Human papillomavirus related cervical cancer and anticipated vaccination challenges in Ethiopia. Int J Health Sci (Qassim). 2016;10(1):137–43.
52.
Schnatz PF, Markelova NV, Holmes D, Mandavilli SR, Sullivan DMO, Ph D. The prevalence of cervical HPV and cytological factors of rural Nigerian women. J Women’s Heal. 2008;17(2):1–7.
53.
Obure J, Olola O, Swai B, Mlay P, Masenga G, Walmer D. Prevalence and severity of cervical squamous intraepithelial lesion in a tertiary hospital in northern Tanzania. Tanzan J Health Res. 2009;11(4):163–9.PubMed
54.
Makurdi H, Swende TZ, Ngwan SD, Swende LT. Prevalence and risk factors for cervical squamous intraepithelial lesions among women infected with HIV-1 in Makurdi, Nigeria. Int J Women’s Heal. 2012;4:55–60.
55.
56.
Adekunle OO, MOAS. Letters to Editor Prevalence of cervical intraepithelial neoplasia in Zaria. Ann Afr Med. 2010;9(3):2010.CrossRef
57.
Durowade KA, Osagbemi GK, Salaudeen AG, Musa OI, Akande TM, Babatunde OA, et al. Prevalence and risk factors of cervical cancer among women in an urban community of Kwara State, North Central Nigeria. J Prev Med Hyg. 2012;53:213–9.PubMed
58.
59.
Sharma P, Rahi MLP. A community-based cervical cancer screening program among women of Delhi using camp approach. IJCM. 2010;35:86–8.
60.
Diop M. HPV and cervical cancer in Senegal; 2013.
61.
Agaba PA, Thacher TD, Ekwempu CC, Idoko JA. Cervical dysplasia in Nigerian women infected with HIV. Int J Gynecol Obstet. 2009;107(2):99–102.CrossRef
62.
Anorlu RI. Prevalence of abnormal cervical smears among patients with HIV in Lagos, Nigeria. West Afr J Med. 2007;26(2):143–7.PubMed
63.
Dim CC, et al. Prevalence of cervical squamous intraepithelial lesions among HIV-positive women in Enugu, South-eastern Nigeria. J Obstet Gynaecol (Lahore). 2011;31(8):759–62.CrossRef
64.
Durowade KA, Hospital FT, State E, Osagbemi G, Salaudeen AG, Musa O. Prevalence and risk factors of cervical cancer among women in an urban community of Kwara State, North Central Nigeria. J Prev Med Hyg. 2012;53:85–8.
65.
Prazzini F, et al. The epidemiology of female genital tract cancers. IJGC. 1997;7:169–81.
Metadata
Title
Precancerous cervical lesion in Ethiopia: systematic review and meta-analysis
Authors
Ayele Semachew Kasa
Tadesse Dagget
Yeshiwork Beyene
Getnet Dessie
Aklilu Endalamaw
Yinager Workineh
Emiru Ayalew
Balew Zeleke
Sitotaw Kerie
Getasew Mulat
Worku Animaw
Publication date
01-12-2021
Publisher
BioMed Central
Published in
Systematic Reviews / Issue 1/2021
Electronic ISSN: 2046-4053
DOI
https://doi.org/10.1186/s13643-021-01840-0

Other articles of this Issue 1/2021

Systematic Reviews 1/2021 Go to the issue

Research

A systematic literature review of attitudes towards secondary use and sharing of health administrative and clinical trial data: a focus on consent

Protocol

The association between hospital financial performance and the quality of care—a scoping review protocol

Protocol

Peer-to-peer health promotion interventions among African American men: a scoping review protocol

Research

Why do some inter-organisational collaborations in healthcare work when others do not? A realist review

Letter

Sexual dysfunction in men with multiple sclerosis

Protocol

The lived experience of people with obesity: study protocol for a systematic review and synthesis of qualitative studies